- With this, they build one of the largest networks of Community based Cancer Treatment and Research Centers
- The merger will enable singular focus on delivering best-in-class Cancer Care
- Post-merger, they will set up districtwise centres in Gujarat, MP& Maharashtra
- The combined entity shall soon expand their operations in other parts of India with aim to provide access to best-quality cancer care to patients across India
NE HEALTH BUREAU
AHMEDABAD, JULY 6
Gujarat-based Hemato Oncology Clinic- Vedanta (HOC) and Maharashtra-based M | O | C Cancer Care & Research Center (M | O | C), two pioneering community cancer care organizations in India announced their merger on Saturday expanding access to world-class cancer care and research to patients across Western India. HOC-Vedanta – M | O | C now has one of the largest geographic footprints in cancer treatment and research, providing cancer patients with timely access to leading-edge cancer care at sustainable rates near their homes.
With the merger, both HOC-Vedanta & M | O | C will combine their complementary strengths and resources to provide the best and most compassionate care possible.
While speaking to the media, Bhavin Shah, Director HOC Vedanta said, “Together, we will amplify our commitment to cancer research. By investing in clinical & observational studies of prospective and retrospective nature for innovative treatment modalities, we will contribute to the global fight against cancer, striving to establish utility of new therapies and repurpose of the existing ones.”
Dr Chandrashekhar Pethe, Senior Medical Oncologist, MOC Cancer Care & Research Centre, said, “With this integration, we are heading towards setting new benchmarks in the direction of achieving institutional excellence; ensuring standardized, evidence-based, high-quality care across all our centers. This merger is not just about combining facilities, but it is about building a holistic institution dedicated to enhanced cancer care.”
They aim to offer a continuum of care that includes prevention, treatment, recovery, palliation and long-term support for patients and their families. M | O | C had raised $10 million from Tata Capital Healthcare Fund in January 2023.
HOC-Vedanta – M | O | C have 40 Medical Oncologists and Hemato-Oncologists on board which is the largest pool of cancer physicians under a single cancer care organization in India so far and will serve 22,000+ cancer patients every year across a network of 22 community cancer care locations in Maharashtra, MP and Gujarat. The combined entity shall soon expand their operations in other parts of India with aim to provide access to best-quality cancer care to patients across India.
The united efforts will ensure that world-class cancer treatment is within reach for all, regardless of location or financial status. Together, HOC-Vedanta & M | O | C will make a profound impact on the lives of cancer patients and their families, offering hope, healing, and the promise of a better future.
Caltius Ventures, Ahmedabad acted as exclusive advisor and JSA acted as legal counsel to HOC- Vedanta for the transaction; whereas Affluence Advisors, Mumbai acted as exclusive advisor and AZB acted as legal counsel to M | O | C for the transaction.
